Infojustice: Graphics Show Rise In US Pharma Exports To India, Patent Grants By India 24/02/2014 by Intellectual Property Watch Leave a Comment Mike Palmedo at Infojustice.org writes: “The U.S. International Trade Commission (ITC) is currently investigating “Indian industrial policies that discriminate against U.S. imports… and the effect those barriers have on the U.S. economy and U.S. jobs.” The investigation was requested by Sen. Hatch, Sen. Baucus, Rep. Camp, and Rep. Levin, and the final report is due to be released in November. Last week it held a series of hearings, where it heard from U.S. business, Indian business, and civil society representatives.”
Battles Over Patents: Is India Changing The Rules Of The Game? 18/02/2014 by Ranjitha Balasubramanyam for Intellectual Property Watch 4 Comments Over the last couple of years, news of pharmaceutical patents and India’s attempts to protect and manage its market has caught the attention of intellectual property observers everywhere and the pharmaceutical industry in particular.
Biopharma Industries, Others Urge Caution In US Patent Reform 12/02/2014 by William New, Intellectual Property Watch Leave a Comment A coalition of large and small companies and organisation – including the leading trade associations for the US pharmaceutical and biotechnology industries – has asked the US Congress to use caution in rewriting patent laws so as not to cause unintended harm to their ability to innovate.
Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February 10/02/2014 by Intellectual Property Watch Leave a Comment Dear Subscribers, CPhI’s 3rd Annual Pharma IPR 2014 conference to take place from 26-28 February, 2014 in Mumbai, India will have techno-legal experts from over 10+ regions speaking on the recent case studies on global Pharma and Biopharma patent laws. Among them, Jeffery Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi LLP from US will be speaking on critical developments in US pharma patent law in the year 2013 which have affected pharma and biopharma industry. He will also share best strategies on how Indian generic-drug and biologics enterprises need to go forward with their US-related projects. Some of the critical concerns he is planning to address include: Which pharmaceutical and diagnostic compounds and processes can even obtain a US patent? Whether the new, cheap and fast patent-challenge procedures are right for Indian companies in the life-sciences area? How to avoid paying the attorney fees for the other side in US litigation and indeed, how an Indian company might turn the tables and have the other side pay the company’s attorney fees? You can view his insights on “US Patent Law in 2013: Winds of Change” by clicking here. To optimise interactions with the audience, he and other global techno-legal experts would also be available in query handling sessions as well as one-on-one meetings, to discuss your concerns related to the US patent system. Click here to go through the detailed programme agenda. You can read more about the conference speakers here. To be a part of this exclusive event, please contact the organisers at +91 (22) 6172 7001 / conferences-india@ubm.com, or register online and take advantage of the special offers for you as you are our subscribers. P.S. You may find one of his earlier presentations on “From Small to Big: Some useful points in the coming shift from customary drugs to biologics” interesting – View the presentation here
Small-Scale Farmers’ Innovation Overlooked In WIPO Negotiations, Panellists Say 07/02/2014 by Maëli Astruc for Intellectual Property Watch 1 Comment A side event hosted by the Quaker United Nations Office (QUNO) this week called on negotiators at the World Intellectual Property Organization to include innovation by small-scale farmers and asked for complementarity of several international instruments dealing with this issue.
Developing Countries Urged To Beat Biopiracy With Patent Examination, Regulatory Frameworks 07/02/2014 by Catherine Saez, Intellectual Property Watch 1 Comment While World Intellectual Property Organization members seek ways to address the issue of biopiracy, speakers at a side event to this week’s negotiations said the phenomenon is widespread. According to them, very few patent applicants source the origin of the resources they have used and on which they seek claims. Some measures can be taken […]
Indigenous Panel At WIPO Asks For International Instrument Compliant With Recognised Rights 06/02/2014 by Maëli Astruc for Intellectual Property Watch Leave a Comment A panel addressing negotiators this week at the World Intellectual Property Organization asserted the property rights of Indigenous Peoples and Local Communities over traditional knowledge and genetic resources and called on delegates to draft an international instrument compliant with their internationally recognised rights.
“No Patents On Seeds” Serves EPO Patent Objection And Free Pepper Soup 03/02/2014 by Intellectual Property Watch 2 Comments 32 farmer, breeder and environmental organisations from 26 countries gathered by the “no-patents-on-seeds” alliance today filed an opposition against a patent on an insect-resistant sweet pepper at the European Patent Office in Munich.
US Highest, India Lowest On US Chamber International IP Index 31/01/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment The United States Chamber of Commerce Global Intellectual Property Center this week released a report ranking 25 countries on their IP environment.
MSF: AstraZeneca Pullout Of Neglected Disease R&D Proof System Broken 31/01/2014 by Intellectual Property Watch Leave a Comment Following news reports that pharmaceutical producer AstraZeneca will end its spending on early stage research and development for tuberculosis, malaria and neglected tropical diseases, Médecins Sans Frontières issued a statement saying the move is further proof that substantive change to the global pharmaceutical R&D system is needed.